Several studies have shown that saroglitazar, a PPARα/γ dual agonist, and curcumin (the principal constituent of turmeric) may be effective in the treatment of NAFLD. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.